Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer

Epidermal growth factor receptor (EGFR) is overexpressed in lung cancer patients. Despite treatment with various EGFR tyrosine kinase inhibitors, recurrence and metastasis of lung cancer are inevitable. Docetaxel (DTX) is an effective conventional drug that is used to treat various cancers. Several...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Mi-So, Lee, Kang-Wook, Choi, Yu-Jeong, Kim, Yun-Gyeong, Hwang, Hyun-Ha, Lee, Seo-Yeon, Jung, Se-Eun, Park, Sun-Ah, Lee, Jin-Hee, Joo, Yong-Joon, Cho, Sung-Gook, Ko, Seong-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395077/
https://www.ncbi.nlm.nih.gov/pubmed/34445110
http://dx.doi.org/10.3390/ijms22168405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395077/
https://www.ncbi.nlm.nih.gov/pubmed/34445110
http://dx.doi.org/10.3390/ijms22168405

Ejemplares similares